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IL-8 in pleural effusion 
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*Departments of *Pulmonary Medicine and jlmmunology, Faculty of Medicine, and $Heybeliada Chest 
Hospital, Istanbul, Turkey 
Interleukin-8 (IL-8) is a recently described potent chemotactic factor that may be involved in the pathogenesis 
of pleural e&sions. To understand the actual mechanisms mediating the inflammatory response, changes in 
cellular components and IL-8 level in pleural fluid of different aetiologies were evaluated. Thirty-four patients 
(19 male, 15 female) with a mean age of 46 f 22 years (range 1692) were included in the study. Of these, 13 
had tuberculous pleural effusion, seven had empyema/parapneumonic pleural effusion, and 14 had malignant 
pleural effusion (seven adenocarcinoma, three ovarian carcinoma, two lymphoma, one chronic myeloid 
leukaemia, and one small cell carcinoma) with positive cytology. Differential cell counts in the pleural fluid 
were obtained using cytocentrifuge preparations. The concentrations of IL-8 in pleural fluid were measured by 
the ELISA method. Interleukin-8 was detected in all 34 pleural fluid samples. The serum IL-8 level was 
analysed only in the empyema/parapneumonic pleural effusion group The mean IL-8 levels of tuberculous, 
empyemalparapneumonic, and malignant pleural effusions were 1420 f 1049 pg ml - ‘, 4737 f 2297 pg ml - i, 
and 1574* 1079pgml-i, respectively. The IL-8 levels in the empyema/parapneumonic group were signifi- 
cantly raised over malignant and tuberculous groups (PcO.02). The mean pleural fluid neutrophil counts 
in tuberculous, empyema/parapneumonic and malignant pleural effusions were 3 15 & 575 cells mm ~ 3, 
11 136 % 12 452 cells mm ~ 3, and 635 & 847 cells mm - 3, respectively (P<O.O03). There was a significant 
positive correlation between pleural IL-8 levels and neutrophil counts (rz0.46, P<O.O06). The levels of IL-8 
in paired samples of serum and pleural fluid in the empyema/parapneumonic effusion group were compared, 
and the concentration of IL-8 was higher in the pleural effusion than serum (means, 4737 * 2297 pg ml ~ i and 
130.0 * 62.5 pg ml - ‘, respectively, PcO.03). There was a significant negative correlation between IL-8 
concentrations in serum and pleural fluid (r= - 0.80, PcO.03). 
This data suggests that production of IL-8 in pleural effusion may play a key role in initiation and 
maintenance of inflammatory reactions, especially in empyema/parapneumonic pleural effusions. It may offer 
the basis for introduction of novel anti-inflammatory agents in treatment. 
Introduction recruitment can result from the concerted action of 
The movement of neutrophils from the peripheral 
blood into inflamed tissue is a fundamental aspect 
of acute inflammation. Several neutrophil chemo- 
attractants have been characterized in recent years; 
the best known being the anaphylatoxin C5a, formyl- 
methionyl peptides of bacterial origin, platelet 
activating factor (PAF), leukotriene B4, neutrophil 
activating factor-2 (NAP-2), and monocyte-derived 
neutrophil chemotactic factor (l-6). These stimuli 
have different origins and modes of formation and 
act via unrelated receptors suggesting that neutrophil 
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multiple stimuli. The effects of these chemoattract- 
ants are not restricted to neutrophils alone; mono- 
cytes and other granulocytes respond to these stimuli 
as well, Recent findings have demonstrated the exist- 
ence of a novel neutrophil activating peptide first 
named NAP-l but subsequently renamed IL-8 (7). It 
appears to be more selective against neutrophils, does 
not stimulate mononuclear phagocytes or platelets, 
and has only borderline effects on eosinophils and 
basophils. Additionally, it has been reported to be 
chemotactic for lymphocytes (7). 
Mononuclear phagocytes, fibroblasts, epithelial 
cells, hepatocytes, alveolar macrophages and 
endothelial cells produce IL-8 in response to stimu- 
lation with inflammation-associated cytokines such 
as TNF, IL-l and lipopolysaccharide (7-9). The 
involvement of NAP-l/IL-8 in disease is suggested by 
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the demonstration of its occurrence in patients with 
psoriasis, arthritis, idiopathic pulmonary fibrosis, 
adult respiratory distress syndrome and Pneumocystis 
carinii infection (10-14). 
It has been shown that IL-8 concentrations are 
elevated in parapneumonic and empyema fluids 
(15-l 7), there being a significant correlation with the 
numbers of neutrophils present (l&17). The impor- 
tance of IL-8 levels in pleural effusions and serum has 
been poorly studied in different disease groups. This 
study first investigated whether IL-8 is present in 
human pleural effusions at physiologically significant 
concentrations and, if so, whether IL-8 levels corre- 
late with the number of neutrophils. Serum IL-8 
levels were determined in patients whose pleural fluid 
levels were high, and these levels were compared with 
those of the pleural fluid. 
Material and Methods 
Thirty-four patients (19 male, 15 female; mean age 
46 * 22 years, range 1692 years) with pleural effu- 
sions were studied. Pleural fluid was obtained by 
diagnostic thoracentesis after informed consent. The 
effusions were first categorized as exudates using 
Light criteria (18). They were further categorized 
as either parapneumonic/empyema, tuberculous or 
malignant. Patients with empyema were defined by 
the following criteria: a positive culture for organ- 
isms, glucose concentration less than 40 mg dl- ’ 
with a pleural fluid pH of less than 7.20. A para- 
pneumonic effusion was defined as an exudative 
effusion associated with a pulmonary parenchymal 
infiltrate with a pleural fluid culture that was negative 
for organisms, a glucose concentration greater than 
40mgdll’, and a pleural fluid pH of more than 
7.20. Tuberculous effusions were defined as those 
with growth on culture of pleural liquid or pleural 
biopsy and/or the presence of caseating granulomas 
on biopsy and/or acid-fast bacilli in fluid, a positive 
purified protein derivative (PPD) skin test, and 
response to anti-tuberculous therapy. A malignant 
pleural effusion was defined by at least one of the 
following criteria: malignant cells in the pleural fluid 
on cytologic examination, or malignancy on closed 
pleural biopsy. Pleural biopsies were obtained using 
standard techniques when tuberculosis or malignancy 
was suspected. A sample of fluid was placed in a 
haemocytometer to estimate the total number of 
white cells. A sample was cytocentrifuged and 
later stained with Wright stain for cell differential 
counts. 
The IL-8 concentrations in pleural fluid super- 
natants of all patients and serums of patients 
with empyema/parapneumonic were measured by a 
sandwich-ELISA method using a commercial-kit 
(Amersham, U.K.). The IL-8 test kit is an enzyme 
immunoassay for the quantitative detection of circu- 
-1ating IL-8 in cell culture supernatants, human 
serum, amniotic or other body fluids. An anti-IL-8 
monoclonal coating antibody is absorbed onto 
polystyrene microwells. Interleukin-8 present in the 
sample or standard binds to antibodies absorbed 
to the microwells; a horseradish peroxidase (HRP) 
conjugated polyclonal antibody is added. and binds to 
the IL-8 captured by the first antibody. Unbound 
enzyme conjugated anti-IL-8 is removed during a 
wash step and the substrate solution reactive with 
HRP is added to the wells. A coloured product is 
formed in proportion to the amount of circulating 
IL-8 present in the sample. The reaction is terminated 
by the addition of acid, and absorbance measured at 
450 nm. A standard curve is prepared from eight IL-8 
standard dilutions in duplicate. Sample values are 
determined from the standard curve. 
All values were expressed as the mean f SD. 
Results were compared using analysis of variance. 
Correlation of neutrophil counts and IL-8 levels was 
determined by simple regression analysis (Spearman- 
Rank). A P value ~0.05 was considered to represent 
a significant difference. 
Results 
The clinical characteristics of the pleural effusions 
are summarized in Table 1. Thirteen patients had 
tuberculosis, seven patients had parapneumonic 
pleural effusion or empyema (three empyema, four 
parapneumonic), and 14 patients had malignant 
pleural effusion (seven adenocarcinoma, three ovar- 
ian carcinoma, two lymphoma, one chronic myeloid 
leukaemia, and one small cell carcinoma of the 
lung). 
Patients with empyema/parapneumonic effusion 
had a marked elevation of their total cell counts, the 
mean being 12 286 * 11 974 cellsmme3. A large 
proportion of these cells were neutrophils with a few 
monocytes and lymphocytes. Patients with malignant 
pleural effusions had a large number of monocytes 
and lymphocytes in the pleural space. Tuberculous 
effusions also contained predominantly mononuclear 
cells (Table 1). 
Interleukin-8 levels in empyema/parapneumonic 
effusions were significantly raised over levels in both 
malignant and tuberculous fluids (PcO.02). In the 
empyema group, the pleural fluid IL-8 levels were 
higher than the parapneumonic group, although the 
number of this group was low (Table 2). In the 
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Table 2 Pleural fluid and serum IL-8 levels in patients with empyema/parapneumonia and pleural fluid IL-8 levels in 
patients with tuberculosis 
No. of 
patients Diagnosis 
Total cell Pleural fluid 
count (mm - 3, IL-8 (pg ml - ‘) 
Serum IL-8 
(pgmlm’) 
1 MO 
2MS 
3 DAS 
4CA 
5AC 
6HA 
7YK 
1 NB 
2 FK 
3 KY 
4MA 
5 SY 
6 Lo 
7Tij 
8AK 
QTB 
10 MY 
11 Ai 
12 SE 
13 EM 
Parapneumonia 1100 6000 70 
Empyema 15 000 6000 137 
Parapneumonia 9900 210 210 
Empyema 28 300 6000 70 
Parapneumonia 1200 2950 209 
Empyema 28 000 6000 72 
Parapneumonia 2500 6000 142 
12285* 11 974 4737 LIZ 2297 130.0 f 62.5 
Tbc (*Culture of fluid+) 80 3300 
Tbc (tBiopsy+) 20 000 500 
Tbc (Biopsy +) 8000 2900 
Tbc (Culture of fluid+) 8000 640 
Tbc (Biopsy+) 10 000 780 
2100 1280 Tbc (Biopsy+) 
Tbc (Culture of fluid+) 8000 1600 
Tbc (Biopsy+, culture of pleura+) 10 000 700 
Tbc (Biopsy+) 800 185 
Tbc (Biopsy+) 786 600 
Tbc (Biopsy+, culture of pleura+) 4700 2100 
Tbc (Biopsy+) 1450 2900 
Tbc (Biopsy+, culture of pleura+) 8000 975 
6301 f 5550 1420 f 1049 
*BACTEC, culture of pleural fluid or pleural tissue; tBiopsy, light microscopic examination showing tuberculous 
granuloma 
tuberculosis group, six of thirteen patients (47%) had 
positive BACTEC culture, IL-8 levels in this culture 
positive group were not statistically different from the 
culture negative group (1553 & 1025 pg ml - ’ and 
1306 * 1138 pg ml - ‘, respectively). The serum IL-8 
levels in patients with empyema/parapneumonic 
were estimated and significantly lower than pleural 
fluid levels (130.0 * 62.5 pg ml - ’ vs. 4737 & 
2297 pg ml - ‘), (P<O.O3), (Table 1). Furthermore, 
Spearman-Rank correlation test revealed a signifi- 
cant negative correlation between serum and pleural 
IL-8 levels in these patients (r= - 0.80, P<O.O3), 
(Fig. 1). In all groups, there was a significant positive 
correlation between pleural IL-8 levels and the abso- 
lute neutrophil count in the fluid (t-=0.46, P<O.O06), 
but not between the neutrophil percentage and IL-8 
levels. However, this significant positive correlation 
may be due to very high neutrophil counts (Fig. 2). 
When the diagnostic groups were considered separ- 
ately, no correlation was found between neutrophil 
counts and IL-8 levels in pleural fluids. There was no 
correlation between peripheral neutrophil counts and 
serum IL-8 levels. 
Discussion 
This study prospectively evaluated pleural fluids 
from 34 patients in an attempt to explain the pre- 
dominance of inflammatory cell types and IL-8 levels 
in different disease entities. The mechanism by which 
neutrophil traffic is controlled in the pleural effusions 
is poorly understood. It was demonstrated that, in 
the empyemalparapneumonic group, the pleural fluid 
u 
I I I I I 
0 1000 2000 3000 4000 5000 6000 7000 
Fig 1 Correlation between serum and pleural Interleukin-8 
levels in patients with empyema/parapneumonic pleural 
effusions (I= - 0.80, WO.03). 
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Pleural IL-8 level (pg ml?) 
Fig 2 Correlation between Interleukin-8 levels and number 
of neutrophils in pleural fluids in all patients (r=0.46, 
PcO.06). 
contained a significantly higher concentration of IL-8 
than pleural fluids secondary to malignancy and 
tuberculosis. The IL-8 concentration correlated with 
the pleural fluid neutrophil count in all groups, and 
the level of IL-8 increased in the pleural space whilst 
decreasing in the serum of patients with empyema/ 
parapneumonic pleural effusions. 
Neutrophils are the major cellular component in 
acute inflammation and predominate in pleural fluid 
resulting from acute inflammation of the pleura. The 
increase in IL-8 concentration within inflammatory 
fluids was probably due to local production of the 
cytokine. Many cells within the pleural space have 
the ability to synthesize IL-8. Recently, it has been 
shown that human pleural mesothelial cells produce 
IL-8 and monocyte chemotactic peptide-1, and thus 
the mesothelium can sequentially regulate neutrophil 
and mononuclear phagocyte recruitment (19,20). 
Other intrapleural cells likely to produce IL-8 include 
macrophages and lymphocytes. Although the pleural 
macrophage has not yet been tested for IL-8 produc- 
tion, alveolar macrophages do produce IL-8 (9). 
Another possible cellular source is the neutrophil 
itself, which has been shown to produce IL-8 in 
response to stimuli (21). Finally, cells in the lung 
adjacent to the pleural space (e.g. lung fibroblasts, 
alveolar type II cells, intraperenchymal neutrophils) 
might produce IL-8 with subsequent leakage into the 
pleural space (22-24). Irrespective of the source of 
stimulus for its production, IL-8 is increased in 
exudative pleural effusions. Recently, Broaddus et al. 
demonstrated that empyema pleural fluid had a 
higher concentration of IL-8 than pleural fluids from 
malignant effusions, tuberculosis, and transudative 
effusions (17). Anthony et al. and Miller et al. 
reported increased IL-8 levels in empyema and para- 
pneumonic effusions (15,16). Similarly, this study has 
confirmed an increase in IL-8 levels in the pleural 
fluid of patients with empyemalparapneumonic as 
compared to that in patients with malignant and 
tuberculous pleural fluids. In the present study, the 
levels of IL-8 found in patients with empyema/ 
parapneumonic were lower than those reported by 
other groups, and those of malignancy/tuberculous 
were higher (15-17). These differences may be due to 
the differences in total and differential cell counts in 
samples. Also different ELISAs might give different 
results. 
The concentrations of IL-8 measured in the 
empyema liquids were at levels consistent with 
physiologic activity. In in vitro studies of IL-8 activa- 
tion of neutrophils, chemotaxis and activation are 
induced between 2.5 and 25 ng ml - ’ depending on 
the assay (25). The IL-8 concentrations in empyema 
fluid are similar and, in fact, somewhat higher than 
those naturally occurring in undiluted human inflam- 
matory liquids (i.e. synovial fluid) that have been 
assayed (11). In the present study, levels of IL-8 as 
high as 6000 pg ml ~ ’ were found. Interleukin-8 has 
been shown to contribute largely to overall chemo- 
tactic activity in empyema fluids. Interestingly, in one 
study, addition of anti-IL-8 antibody decreased 
neutrophil migration by 65 f. 5% (17). In another 
study, removal of the IL-8 from the fluid reduced 
chemotactic activity between 20% and 90% (16). 
Antony et al. demonstrated that addition of anti-IL-8 
antibody decreased neutrophil chemotaxis by 
32.3 * 3.28% (15). Interleukin-8 is therefore unlikely 
to be the only source of neutrophil chemotaxis in 
the pleural space. It appears, however, to be an 
important contributor to neutrophil chemotactic 
bioactivity in empyema fluid. 
In the present study, there was a correlation 
between pleural fluid IL-8 levels and pleural fluid 
neutrophil counts when all patients were analysed 
together, but this correlation failed when results from 
the empyema/parapneumonic group were examined 
alone. A possible explanation for this difference is 
that neutrophil chemokines other than IL-8 are pri- 
marily responsible for the chemotactic activity for 
neutrophils in parapneumonic effusions, or alterna- 
tively the sample sizes may have been too small to 
yield a statistical difference. Anthony et al. found a 
similar negative correlation in the parapneumonic 
group although reporting a positive significant corre- 
lation between IL-8 levels and the total numbers 
of neutrophils in empyema fluids (r=0.80) (15). 
Broaddus et al. found a similar positive correlation in 
all groups (rzO.46) (17). Miller could find no signifi- 
cant difference between the mean percentage of 
neutrophils in pleural fluids and IL-8 levels (16). 
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Similarly, in the present study, no correlation was 
found between percentage of neutrophils and IL-8 
levels. 
Circulating plasma concentrations of mediators 
are likely to be important in the pathogenesis of 
inflammatory diseases. In a study by Donnelly, serum 
IL-8 levels were detected in patients with adult respi- 
ratory distress syndrome (ARDS) (26). No significant 
relation with ARDS development was found for 
blood IL-8 measurements. Serum levels were between 
41200pgml-’ and Opgml-‘, with a mean of 
5120 f 2220 pg ml - ’ (26). In another study, IL-8 
levels in the sera of patients with different clinical 
manifestations of meningococcal disease were inves- 
tigated and detected in 45% of patients with the 
highest incidence in septic shock. The authors 
reported the concentrations of IL-8 in cerebrospinal 
fluid to be higher than those of serum. There was, 
however, a significant negative association between 
serum IL-8 levels and the peripheral blood leucocyte 
counts (r= - 0.41, P<O.OOl) (27). Serum IL-8 levels 
were determined in empyema/parapneumonic 
patients in this study. The findings were interesting 
because as pleural fluid level of IL-8 increased, serum 
levels dropped. Interleukin-8 appears to be compart- 
mentalized to the pleural space in patients with 
neutrophilic pleural effusions. Although experimental 
evidence is lacking, the high levels of neutrophils 
encountered in the pleural fluid may contribute to 
the production of IL-8 although macrophages and 
mesothelial cells may also be sources of IL-8. To the 
authors’ knowledge, this clinical study is the first 
to identify the serum IL-8 levels in patients with 
neutrophilic pleural effusion. However, the measure- 
ments of serum levels were only taken in the group 
of patients with empyemalparapneumonic effusions 
(seven of 34 patients). The lack of correlation 
between the IL-8 levels and the number of neu- 
trophils in serum is difficult to define. This may be 
due to the difference of total and differential cell 
counts in the pleural fluid and serum. 
Recently, the instillation of some drugs for pleuro- 
desis such as tetracycline and talc have been shown to 
cause temporary IL-8 production and neutrophilic 
inflammation in the plural space (28,29). The mech- 
anism by which IL-8 is produced in the pleural and 
its role in pleurodesis remains unelucidated. 
The results of this study suggest that IL-8 may play 
a key role in recruiting neutrophils into the inflamed 
pleural space. Further studies of IL-8 and its role in 
the cytokine network in pleura and blood will be of 
major importance for the understanding of the patho- 
genesis of infectious diseases, and may ultimately 
have an impact on the treatment of severe infections. 
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